Protective effect of isoorientin-2'-O-α-l-arabinopyranosyl isolated from Gypsophila elegans on alcohol induced hepatic fibrosis in rats

Food and Chemical Toxicology

Volumn 50, Issue 6, 2012, Pages 1992-2001

  Huang, Quan Fang ^a   Zhang, Shi Jun ^b   Zheng, Li ^b   Liao, Ming ^b   He, Min ^b   Huang, RenBin ^b   Zhuo, Lang ^c   Lin, Xing ^b  

^a GUANGXI UNIVERSITY OF CHINESE MEDICINE   (China)

^b GUANGXI MEDICAL UNIVERSITY   (China)

^c INSTITUTE OF BIOENGINEERING AND NANOTECHNOLOGY   (Singapore)

Author keywords

Alcohol; Gypsophila elegans; Isoorientin 2' O l arabinopyranosyl; Liver fibrosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; ALKALINE PHOSPHATASE; ALPHA SMOOTH MUSCLE ACTIN; ANTIFIBROTIC AGENT; ASPARTATE AMINOTRANSFERASE; COLCHICINE; COLLAGEN; GAMMA GLUTAMYLTRANSFERASE; HYALURONIC ACID; INTERLEUKIN 6; ISOORIENTIN 2'' O ALPHA ARABINOPYRANOSYL; LAMININ; MESSENGER RNA; MYELOPEROXIDASE; PROCOLLAGEN; PROTEIN BCL 2; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG ISOLATION; DRUG MECHANISM; DRUG MEGADOSE; DRUG STRUCTURE; ENZYME ACTIVITY; GYPSOPHILA ELEGANS; HISTOPATHOLOGY; LIPID PEROXIDATION; LIVER CELL; LIVER FIBROSIS; LIVER FUNCTION; LIVER INJURY; LIVER PROTECTION; LOW DRUG DOSE; MALE; MEDICINAL PLANT; NONHUMAN; PROTEIN EXPRESSION; RAT;

ACTINS; ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ANIMALS; ANTIOXIDANTS; APOPTOSIS; ASPARTATE AMINOTRANSFERASES; BLOTTING, WESTERN; CARYOPHYLLACEAE; COLCHICINE; DISACCHARIDES; FLAVONES; HEPATITIS, ALCOHOLIC; LIPID PEROXIDATION; LIVER; LIVER CIRRHOSIS; MALE; OXIDATIVE STRESS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION; TRANSFORMING GROWTH FACTOR BETA1;

GYPSOPHILA ELEGANS; RATTUS;

EID: 84860124420     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2012.03.044     Document Type: Article

References (37)

1. Altas S., Kizil G., Kizil M., Ketani A., Haris P.I. Protective effect of Diyarbakir watermelon juice on carbon tetrachloride-induced toxicity in rats. Food Chem. Toxicol. 2011, 49:2433-2438.
2. Bonis P.A., Friedman S.L., Kaplan M.M. Is liver fibrosis reversible?. New Engl. J. Med. 2001, 344:452-454.
3. Bosetti C., Levi F., Lucchini F., Zatonski W.A., Negri E., La V.C. Worldwide mortality from cirrhosis: an update to 2002. J. Hepatol. 2007, 46:827-839.
4. Comporti M., Signorini C., Arezzini B., Vecchio D., Monaco B., Gardi C. Isoprostanes and hepatic fibrosis. Mol. Aspects Med. 2008, 29:43-49.
5. Erdamar H., Türközkan N., Ekremoĝlu M., Kurt Y., Yaman H. The effect of taurine on polymorphonuclear leukocyte functions in endotoxemia. Amino Acids 2007, 33:581-585.
6. Erşahi{dotless}n M., Toklu H.Z., Erzi{dotless}k C., Akakin D., Teti{dotless}k S., Sener G., Yeĝen B.C. Ghrelin alleviates spinal cord injury in rats via its anti-inflammatory effects. Turk. Neurosurg. 2011, 4:599-605.
7. Galli A., Crabb D., Price D., Ceni E., Salzano R., Surrenti C., Casini A. Peroxisome proliferator-activated receptor gamma transcriptional regulation is involved in platelet-derived growth factor-induced proliferation of human hepatic stellate cells. Hepatology 2000, 31:101-108.
8. Gressner A.M., Weiskirchen R. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. J. Cell. Mol. Med. 2006, 10:76-99.
9. Hoek J.B., Pastorino J.G. Cellular signaling mechanisms in alcohol-induced liver damage. Semin. Liver Dis. 2004, 24:257-272.
10. Iimuro Y., Brenner D.A. Matrix metalloproteinase gene delivery for liver fibrosis. Pharm. Res. 2008, 25:249-258.
11. Ji G., Wang L., Zhang S.H., Liu J.W., Zheng P.Y., Liu T. Effect of Chinese medicine Qinggan Huoxuefang on inducing HSC apoptosis in alcoholic liver fibrosis rats. World J. Gastroenterol. 2006, 12:2047-2052.
12. Karsan H.A., Rojter S.E., Saab S. Primary prevention of cirrhosis. Pubic health strategies that can make a difference. Postgrad Med. 2004, 1:25-30.
13. Kirshenbaum L.A., de Moissac D. The bcl-2 gene product prevents programmed cell death of ventricular myocytes. Circulation 1997, 96:1580-1585.
14. Li J., Liu P., Zhang R., Cao L., Qian H., Liao J., Xu W., Wu M., Yin Z. Icaritin induces cell death in activated hepatic stellate cells through mitochondrial activated apoptosis and ameliorates the development of liver fibrosis in rats. J. Ethnopharmacol. 2011, 1:714-723.
15. Lieber C.S. Ethanol metabolism, cirrhosis and alcoholism. Clin. Chim. Acta 1997, 257:59-84.
16. Lieber C.S. Alcohol and the liver: metabolism of alcohol and its role in hepatic and extrahepatic diseases. Mt. Sinai J. Med. 2000, 67:84-94.
17. Miyahara T., Schrum L., Rippe R., Xiong S., Yee H.F., Motomura K., Anania F.A., Willson T.M., Tsukamoto H. Peroxisome proliferator-activated receptors and hepatic stellate cell activation. J. Biol. Chem. 2000, 275:35715-35722.
18. Nanji A.A., Jokelainen K., Fotouhinia M., Rahemtulla A., Thomas P., Tipoe G.L., Su G.L., Dannenberg A.J. Increased severity of alcoholic liver injury in female rats:role of oxidative stress, endotoxin, and chemokines. Am. J. Physiol. Gastrointest. Liver Physiol. 2001, 281:G1348-G1356.
19. Neuman M.G. Cytokines-central factors in alcoholic liver disease. Alcohol Res. Health 2003, 27:307-316.
20. Safadi R., Friedman S.L. Hepatic fibrosis-role of hepatic stellate cell activation. Med. Gen. Med. 2002, 4:27.
21. Seki E., Brenner D.A. Toll-like receptors and adaptor molecules in liver disease: update. Hepatology 2008, 48:322-335.
22. Shaker M.E., Salem H.A., Shiha G.E., Ibrahim T.M. Nilotinib counteracts thioacetamide-induced hepatic oxidative stress and attenuates liver fibrosis progression. Fundam. Clin. Pharmacol. 2011, 2:248-257.
23. Shanmugam L.D., Periyaswamy V., Carani V.A. Taurine enhances the metabolism and detoxification of ethanol and prevents hepatic fibrosis in rats treated with iron and alcohol. Environ. Toxicol. Phar. 2009, 27:120-126.
24. Shek F.W., Benyon R.C. How can transforming growth factor beta be targeted usefully to combat liver fibrosis?. Eur. J Gastroen. Hepat. 2004, 16:123-126.
25. 4 via inhibition of hepatic stellate cells activation. Food Chem. Toxicol. 2008, 46:3707-3713.
26. Song N., Wang R.R., Li Z.L., Liu X.Q. Structure determination of a flavonoid glycoside extracted from Capsella bursa-pastoris (L.) Medic. by NMR spectroscopy. Chin. J. Magn. Reson. 2009, 26:88-94.
27. Toda K., Kumagai N., Tsuchimoto K., Inagaki H., Suzuki T., Oishi T., Atsukawa K., Saito H., Morizane T., Hibi T., Ishii H. Induction of hepatic stellate cell proliferation by LPS-stimulated peripheral blood mononuclear cells from patients with liver cirrhosis. J. Gastroenterol. 2000, 35:214-220.
28. Tommaso M., Elisabetta C., Calogero S., Andrea G. Alcohol induced hepatic fibrosis: role of acetaldehyde. Mol. Aspects Med. 2008, 29:17-21.
29. Tsukamoto H., Rippe R., Niemelä O., Lin M. Roles of oxidative stress in activation of Kupffer and Ito cells in liver fibrogenesis. J. Gastroenterol. Hepatol. 1995, 10:S50-S53.
30. Weng H., Mertens P.R., Gressner A.M., Dooley S. IFN-gamma abrogates profibrogenic TGF-beta signaling in liver by targeting expression of inhibitory and receptor Smads. J. Hepatol. 2007, 46:295-303.
31. Whitfield J.B. Gamma glutamyl transferase. Crit. Rev. Clin. Lab. Sci. 2001, 38:263-355.
32. Zhang F.M., Tai Z.G., Cai L., Yang Y.B., Li F., Ding Z.T. Flavonoids from Gypsophila elegans and their antioxidant activities. J. Yunnan Univ. 2011, 33:93-95.
33. Zhang S.H., Ji G., Liu J.W. Reversal of chemical-induced liver fibrosis in Wistar rats by puerarin. J. Nutr. Biochem. 2006, 17:485-491.
34. Zhang S.J., Chen Z.N., Zhang Z.W., Liu X., Fu S.J., Huang R.B. Inhibitory effect of compound Liuyueqing on synthesis of collagen type I in hepatic tissues in rats with hepatic fibrosis. Chin. J. Exp. Trad. Med. Formulae 2010, 16:140-143.
35. Zhang S.J., Chen Z.N., Lin X., Huang J.C., Li Y.W., Huang R.B. Protective effect of compound Liuyueqing against duck liver injury induced by duck hepatitis B virus. Lishizhen Med. Mat. Med. Res. 2011, 22:1582-1583.
36. Zhang X.H., Yan M., Liu L., Wu T.J., Ma L.L., Wang L.X. Expression of discoidin domain receptors (DDR2) in alcoholic liver fibrosis in rats. Arch. Med. Res. 2010, 41:586-592.
37. Zou Y.H., Yang Y., Li J., Wu Q., Li W.P., Lu J.T., Roberts M.S. Potential therapeutic effects of a traditional Chinese formulation, BJ-JN, on liver fibrosis induced by carbon tetrachloride in rats. J. Ethnopharmacol. 2008, 120:452-457.